Trial Profile
A Phase I Study of Epothilone B Analog BMS 247550 in Combination With Carboplatin in Recurrent and/or Refractory Solid Tumors
Status:
Discontinued
Phase of Trial:
Phase I
Latest Information Update: 07 Nov 2021
Price :
$35
*
At a glance
- Drugs Carboplatin (Primary) ; Ixabepilone (Primary)
- Indications Solid tumours
- Focus Adverse reactions
- 26 Jan 2013 New trial record